Design of the Del-1 for therapeutic angiogenesis trial (DELTA-1), a phase II multicenter, double-blind, placebo-controlled trial of VLTS-589 in subjects with intermittent claudication secondary to peripheral arterial disease

Sanjay Rajagopalan, Jeffrey W. Olin, Stuart Young, Marlena Erikson, Paul M. Grossman, Farrell O. Mendelsohn, Judith G. Regensteiner, William R. Hiatt, Brian H. Annex

Research output: Contribution to journal › Article › peer-review

28 Scopus citations

Fingerprint

Dive into the research topics of 'Design of the Del-1 for therapeutic angiogenesis trial (DELTA-1), a phase II multicenter, double-blind, placebo-controlled trial of VLTS-589 in subjects with intermittent claudication secondary to peripheral arterial disease'. Together they form a unique fingerprint.

Medicine & Life Sciences